Search Results 211-220 of 21642 for depression

  1. Venlafaxine (oral route) - Side effects & dosage - Mayo Clinic

    Venlafaxine is used to treat depression. It is also used to treat general anxiety disorder, social anxiety disorder, and panic disorder. Venlafaxine belongs to ...

  2. Paroxetine (oral route) - Side effects & dosage - Mayo Clinic

    Description. Paroxetine is used to treat depression, obsessive-compulsive disorder (OCD), panic disorder, generalized anxiety disorder (GAD), social anxiety ...

  3. Improving Care for Adolescents Aged 12-17 in Primary Care with Clinical Symptoms of Depression - Mayo Clinic

    Increase screening of adolescents for symptoms of depression in primary care La Crosse, WI clinics using the PHQ9M screening tool.Screening to occur at all well ...

  4. Mayo Clinic Minute 5 signs your teenager is battling depression SCRIPT

    “So depression is much more common than most people realize. This is something that affects teenagers of all walks of life, of all backgrounds, and.

  5. Suicide and suicidal thoughts - Diagnosis and treatment - Mayo Clinic

    Depending on your state of mind, you may need medications to calm you or to ease symptoms of an underlying mental illness, such as depression. Your doctor ...

  6. rTMS for Depressed Teens: A Sham-Controlled Trial, Part 2 - Mayo Clinic

    This research proposal aims to better understand the neurobiology of depression in adolescents and how repetitive transcranial magnetic stimulation (rTMS) may ...

  7. Coping with anxiety: Can diet make a difference? - Mayo Clinic

    Depression and anxiety: Can I have both? Herbal treatment for anxiety: Is it effective? Share · Tweet. Dec. 17, 2024. Show references. Rakel D, et al., eds ...

  8. Voice Analysis Technology to Detect and Manage Depression and Anxiety in Cardiac Rehabilitation - Mayo Clinic

    ... depression and anxiety to cardiac prognosis resulting in improved quality of life and diagnosis. Participation eligibility. Participant eligibility includes ...

  9. The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression. - Mayo Clinic

    The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II ...

  10. Depression Screening/Common Blood Tests/NEAT and Weight Management: Mayo Clinic Radio

    According to the Centers for Disease Control and Prevention, about 8 million adults in the U.S. are diagnosed with depression each year.